Intelligent cardiac monitoring webinar series.
WEBINAR 1
Martin S. Maron, MD

Insights on ECG monitoring in assessing risk of sudden cardiac death.

Thursday, August 11, 2022
Session 1: 9:30 a.m. PT  |  12:30 p.m. ET
Session 2: 5:30 p.m. PT  |  8:30 p.m. ET
45 minutes

Join us for a discussion with Dr. Martin Maron, Director of the Hypertrophic Cardiomyopathy Center (HCM) at Lahey Hospital & Medical Center. Dr. Maron will share recent data from an HCM center and research institute demonstrating the potential impact of longer ambulatory monitoring time in identifying a greater burden of non-sustained ventricular tachycardia (NSVT), which has potential implications on patient management.

In this webinar:

  • Monitoring with Zio XT for 8-14 days vs 3-7 days identified more NSVT (40% vs 26%, respectively).1
  • Case study illustrates two brands of ambulatory ECG patch monitors found significantly different burdens of NSVT.2
  • Arrhythmia detection affected by monitor algorithm thresholds.3

Martin S. Maron, MD 

Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital & Medical Center

WEBINAR 2
Mark J. Day, PhD

AI and the power of data.

Wednesday, August 31, 2022
Session 1: 9:30 a.m. PT  |  12:30 p.m. ET
Session 2: 5:30 p.m. PT  |  8:30 p.m. ET
45 minutes

Join us for a discussion with Mark J. Day, Chief Technology Officer of iRhythm. Mr. Day will discuss the evolution of AI-assisted technology in aiding with cardiac arrhythmia detection and diagnosis, share significant research in ambulatory ECG monitoring accuracy, and explain how advances in wearable devices could lead to predictive capabilities in the future for you and your practice.

 

In this webinar:

 

  • Gain a new understanding of the technology that powers ECG monitors.
  • Discover why not all algorithms are equal.
  • Learn how next-generation healthcare wearables could impact patient care.

Mark J. Day, PhD

Chief Technology Officer, iRhythm Technologies

Register to attend live, or
sign up to receive a recording.

Martin S. Maron, MD
Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital & Medical Center

Dr. Martin Maron is Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital & Medical Center. His research interests are the diagnosis and management of hypertrophic cardiomyopathy, including identification of patients at high risk for sudden death as well as the role of cardiovascular magnetic resonance and ambulatory monitoring in assessment of patients with HCM and novel drug therapy to modify the disease. Dr. Maron has co-authored over 250 original publications on HCM including in The New England Journal of Medicine, The Lancet, Circulation, and Journal of the American College of Cardiology.

Mark J. Day, PhD

Chief Technology Officer of iRhythm Technologies

Mark J. Day serves as iRhythm’s Chief Technology Officer and was formerly the Executive Vice President of Research & Development. He has had other leadership roles in Research & Development and Systems Development since joining iRhythm in 2007. Previously, he worked in Medtronic’s Cardiac Rhythm Disease Management division. Prior to that, Mr. Day was Chief Technology Officer of CarePages, Inc., a blogging site for patients. Mr. Day has an MBA in Marketing from the Wharton School, University of Pennsylvania; a PhD in Computation Flow Physics from Stanford University; an MS in Mechanical Engineering from Stanford University; and a BSc in Mechanical Engineering from Queen’s University.

  1. Data on file. iRhythm Technologies, 2019.
  2. Individual facility results may vary.
  3. Fabrizio Guarracini et al. "Programming Optimization in Implantable Cardiac Monitors to Reduce False-Positive Arrhythmia Alerts: A Call for Research." Diagnostics, 2022. https://www.mdpi.com/2075-4418/12/4/994/htm